RIGL icon

Rigel Pharmaceuticals

121 hedge funds and large institutions have $528M invested in Rigel Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 52 increasing their positions, 21 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
121
Holders Change
+13
Holders Change %
+12.04%
% of All Funds
2.75%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
28
Increased
52
Reduced
21
Closed
15
Calls
$1.43M
Puts
$341K
Net Calls
+$1.09M
Net Calls Change
+$793K
Name Holding Trade Value Shares
Change
Shares
Change %
EGM
126
Engineers Gate Manager
New York
-$80K -3,143 Closed
Balyasny Asset Management
127
Balyasny Asset Management
Illinois
-$51K -2,010 Closed
TRCT
128
Tower Research Capital (TRC)
New York
-$49K -1,938 Closed
ARTA
129
A.R.T. Advisors
New York
-$39K -1,550 Closed
Squarepoint
130
Squarepoint
New York
-$33K -1,294 Closed
BCM
131
BlueCrest Capital Management
Jersey
-$27K -1,055 Closed
Connor, Clark & Lunn Investment Management (CC&L)
132
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$26K -1,014 Closed
NFG
133
Next Financial Group
Texas
-$7K -195 Closed
Bank of Montreal
134
Bank of Montreal
Ontario, Canada
-$2K -89 Closed
MA
135
MUFG Americas
New York
-$2K -66 Closed